Bionano Genomics (BNGO) Current Assets (2017 - 2026)

Bionano Genomics' Current Assets history runs 10 years deep, the most recent figure standing at $39.0 million for Q1 2026.

• In Q1 2026, Current Assets fell 13.25% year-over-year to $39.0 million; the TTM figure through Mar 2026 stood at $39.0 million (down 13.25% YoY), while the FY2025 annual figure was $45.4 million, up 14.93% from the prior year.
• Current Assets came in at $39.0 million for Q1 2026 at Bionano Genomics, down from $45.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $242.4 million in Q1 2022 to a low of $39.0 million in Q1 2026.
• A 5-year average of $105.7 million and a median of $85.6 million in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets sank 71.82% in 2024 and climbed 14.93% in 2025, its largest moves.
• Bionano Genomics' Current Assets stood at $157.3 million in 2022, then slipped by 10.92% to $140.1 million in 2023, then tumbled by 71.82% to $39.5 million in 2024, then grew by 14.93% to $45.4 million in 2025, then retreated by 14.13% to $39.0 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $39.0 million, $45.4 million, and $48.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison